Made specifically for people taking GLP-1 medications, this one contains a multivitamin, calcium and D3, magnesium, and vitamin B12
These medications can lead to muscle loss along with fat loss
Previous microneedle patches for the same drug achieved only around 30% bioavailability
4.5 Safety profile The safety assessment of GLP-1 receptor agonists indicates a mostly gastrointestinal side effect profile, characterised by dose-dependent symptoms that are often treatable by meticulous titration (Madsbad 2016)
Ultra-processed foods tend to be low in fiber and micronutrients, making them less helpful when total intake is reduced
Effects last with just one injection per week Conventional GLP-1 receptor agonists mainly required taking medication once or more per day, but Mounjaro's effects last with just one subcutaneous injection per week, which is another benefit of Mounjaro as it reduces the burden